HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Inhibition of the JAK-STAT3 signaling pathway by ganoderic acid A enhances chemosensitivity of HepG2 cells to cisplatin.

Abstract
Ganoderic acid A is a lanostane triterpene isolated from Ganoderma lucidum. It has been reported to exhibit antitumor activity, which is mainly mediated through its inhibitory effect on nuclear transcription factor-kappaB and activator protein-1. But the role of ganoderic acid A in JAK-STAT3 signaling pathways is still unclear. In the present study, we investigated the effect of ganoderic acid A on the signal transducer and activator of the transcription 3 pathway and evaluated whether suppression of the signal transducer and activator of transcription 3 activity by ganoderic acid A could sensitize HepG2 cells to cisplatin. Our results show that ganoderic acid A significantly suppressed both the constitutively activated and IL-6-induced signal transducer and activator of transcription 3 phosphorylation in HepG2 cells. Inhibition of the signal transducer and activator of transcription 3 tyrosine phosphorylation was found to be achieved through suppression of JAK1 and JAK2. Furthermore, ganoderic acid A promoted cisplatin-induced cell death by enhancing the sensitivity of HepG2 cells to cisplatin mainly via the signal transducer and activator of transcription 3 suppression. These observations suggest a potential therapeutic strategy of using ganoderic acid A in combination with chemotherapeutic agents for cancer treatment.
AuthorsXiangyang Yao, Guilan Li, Hui Xu, Chaotian Lü
JournalPlanta medica (Planta Med) Vol. 78 Issue 16 Pg. 1740-8 (Nov 2012) ISSN: 1439-0221 [Electronic] Germany
PMID22961117 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
CopyrightGeorg Thieme Verlag KG Stuttgart · New York.
Chemical References
  • Antineoplastic Agents, Phytogenic
  • Heptanoic Acids
  • IL6 protein, human
  • Interleukin-6
  • STAT3 Transcription Factor
  • STAT3 protein, human
  • Lanosterol
  • ganoderic acid A
  • Luciferases
  • JAK1 protein, human
  • JAK2 protein, human
  • Janus Kinase 1
  • Janus Kinase 2
  • Cisplatin
Topics
  • Antineoplastic Agents, Phytogenic (pharmacology)
  • Apoptosis
  • Blotting, Western
  • Cell Nucleus (metabolism)
  • Cisplatin (pharmacology)
  • Dose-Response Relationship, Drug
  • Flow Cytometry
  • Genes, Reporter
  • Hep G2 Cells
  • Heptanoic Acids (pharmacology)
  • Humans
  • Interleukin-6 (metabolism)
  • Janus Kinase 1 (metabolism)
  • Janus Kinase 2 (metabolism)
  • Lanosterol (analogs & derivatives, pharmacology)
  • Luciferases (genetics, metabolism)
  • Phosphorylation
  • STAT3 Transcription Factor (genetics, metabolism)
  • Signal Transduction (drug effects)
  • Transcriptional Activation
  • Transfection

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: